Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity

Tomokazu Amano(Elixir Medical (United States)), Minoru S.H. Ko(Elixir Medical (United States))
bioRxiv (Cold Spring Harbor Laboratory)
September 6, 2022
Cited by 2


Related Papers